<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Idarubicin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:59 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Idarubicin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Idarubicin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Idarubicin_files/filelist.xml">
<title>IDARUBICIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VS35</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:06:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:25:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1521</o:Words>
  <o:Characters>8674</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>72</o:Lines>
  <o:Paragraphs>20</o:Paragraphs>
  <o:CharactersWithSpaces>10175</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	page-break-before:always;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:Tahoma;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>IDARUBICIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tên chung qu&#7889;c t&#7871;</span></b><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>: Idarubicin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Mã ATC</span></b><span lang=DE style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;mso-ansi-language:DE'>: L01D B06.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Lo&#7841;i thu&#7889;c: </span></b><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#7889;ng ung th&#432;/kháng sinh &#273;&#7897;c t&#7871;
bào/thu&#7889;c xen gi&#7919;a c&#7863;p ADN/kháng sinh lo&#7841;i anthra -
cyclin.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>L&#7885; thu&#7889;c b&#7897;t &#273;&#7875; tiêm dùng 1
l&#7847;n: 5 mg, 10 mg, 20 mg idarubicin hydroclorid.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Idarubicin là 4 - demethoxy daunorubicin. Idarubicin là m&#7897;t
thu&#7889;c t&#432;&#417;ng t&#7921; daunorubicin, xen vào gi&#7919;a các c&#7863;p
base c&#7911;a DNA, có tác d&#7909;ng &#7913;c ch&#7871; t&#7893;ng h&#7907;p
acid nucleic, t&#432;&#417;ng tác v&#7899;i topoisomerase II và c&#361;ng
t&#432;&#417;ng tác v&#7899;i màng t&#7871; bào và bi&#7871;n &#273;&#7893;i ch&#7913;c
n&#259;ng màng; &#273;i&#7873;u này có th&#7875; góp m&#7897;t ph&#7847;n quan
tr&#7885;ng trong c&#7843; tác d&#7909;ng ch&#7889;ng ung th&#432; và gây
&#273;&#7897;c cho tim c&#7911;a thu&#7889;c. Trong c&#7845;u trúc anthracyclin
c&#7911;a idarubicin, không có nhóm methoxy &#7903; v&#7883; trí 4, nên thu&#7889;c
có ái l&#7921;c cao v&#7899;i lipid và do &#273;ó t&#259;ng kh&#7843; n&#259;ng
thâm nh&#7853;p t&#7871; bào so v&#7899;i các anthracyclin khác.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>&#7902; ng&#432;&#7901;i l&#7899;n b&#7883; b&#7879;nh b&#7841;ch
c&#7847;u v&#7899;i ch&#7913;c n&#259;ng th&#7853;n và gan bình th&#432;&#7901;ng,
sau khi &#273;&#432;&#7907;c tiêm t&#297;nh m&#7841;ch 10 &#273;&#7871;n 12
mg/m<sup>2</sup> indarubicin m&#7895;i ngày trong 3 &#273;&#7871;n 4 ngày,
&#273;i&#7873;u tr&#7883; &#273;&#417;n &#273;&#7897;c ho&#7863;c ph&#7889;i h&#7907;p
v&#7899;i cytarabin th&#7845;y có m&#7897;t giai &#273;o&#7841;n phân b&#7889;
nhanh v&#7899;i th&#7875; tích phân b&#7889; r&#7845;t cao, &#273;i&#7873;u
&#273;ó ch&#7913;ng t&#7887; thu&#7889;c g&#7855;n m&#7841;nh vào mô. Ð&#7897;
thanh th&#7843;i huy&#7871;t t&#432;&#417;ng g&#7845;p 2 l&#7847;n l&#432;u
l&#432;&#7907;ng huy&#7871;t t&#432;&#417;ng d&#7921; ki&#7871;n x&#7843;y ra &#7903;
gan, ch&#7913;ng t&#7887; chuy&#7875;n hóa ngoài gan m&#7841;nh. Thu&#7889;c
&#273;ào th&#7843;i ch&#7911; y&#7871;u qua m&#7853;t và &#7903; m&#7913;c
&#273;&#7897; ít h&#417;n qua th&#7853;n, ph&#7847;n l&#7899;n d&#432;&#7899;i
d&#7841;ng ch&#7845;t chuy&#7875;n hóa ban &#273;&#7847;u (idarubicinol).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>T&#7889;c &#273;&#7897; &#273;ào th&#7843;i idarubicin ra
kh&#7887;i huy&#7871;t t&#432;&#417;ng ch&#7853;m, v&#7899;i n&#7917;a &#273;&#7901;i
cu&#7889;i &#432;&#7899;c tính trung bình 22 gi&#7901; (ph&#7841;m vi: 4 &#273;&#7871;n
46 gi&#7901;) khi dùng &#273;&#417;n &#273;&#7897;c và 20 gi&#7901; (ph&#7841;m
vi: 7 &#273;&#7871;n 38 gi&#7901;) khi dùng ph&#7889;i h&#7907;p v&#7899;i
cytarabin. Idarubicinol &#273;ào th&#7843;i ch&#7853;m h&#417;n nhi&#7873;u so
v&#7899;i idarubicin, v&#7899;i n&#7917;a &#273;&#7901;i cu&#7889;i &#432;&#7899;c
tính trung bình trên 45 gi&#7901;, do &#273;ó n&#7891;ng &#273;&#7897;
idarubicinol trong huy&#7871;t t&#432;&#417;ng &#273;&#432;&#7907;c duy trì dài
h&#417;n 8 ngày. Vì idarubicinol c&#361;ng có ho&#7841;t tính &#273;&#7897;c t&#7871;
bào nên có th&#7875; góp ph&#7847;n vào tác d&#7909;ng c&#7911;a idarubicin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>&#7902; ng&#432;&#7901;i r&#7889;i lo&#7841;n ch&#7913;c
n&#259;ng gan v&#7915;a ho&#7863;c n&#7863;ng, chuy&#7875;n hóa idarubicin có
th&#7875; b&#7883; r&#7889;i lo&#7841;n và d&#7851;n &#273;&#7871;n n&#7891;ng
&#273;&#7897; thu&#7889;c toàn thân cao h&#417;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>N&#7891;ng &#273;&#7897; &#273;&#7881;nh idarubicin trong
t&#7871; bào &#273;&#7841;t &#273;&#432;&#7907;c ít phút sau khi tiêm. N&#7891;ng
&#273;&#7897; idarubicin và idarubicinol trong t&#7871; bào máu có nhân và t&#7871;
bào t&#7911;y g&#7845;p h&#417;n m&#7897;t tr&#259;m l&#7847;n n&#7891;ng
&#273;&#7897; trong huy&#7871;t t&#432;&#417;ng. T&#7889;c &#273;&#7897; m&#7845;t
&#273;i c&#7911;a idarubicin trong huy&#7871;t t&#432;&#417;ng và trong t&#7871;
bào t&#432;&#417;ng t&#7921; nh&#432; nhau, v&#7899;i n&#7917;a &#273;&#7901;i
cu&#7889;i kho&#7843;ng 15 gi&#7901;. N&#7917;a &#273;&#7901;i cu&#7889;i c&#7911;a
idarubicinol trong t&#7871; bào là kho&#7843;ng 72 gi&#7901;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Idarubicin và idarubicinol g&#7855;n vào protein huy&#7871;t
t&#432;&#417;ng ng&#432;&#7901;i v&#7899;i t&#7927; l&#7879; t&#432;&#417;ng &#7913;ng
97% và 94%.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>N&#7891;ng &#273;&#7897; idarubicin và ch&#7845;t chuy&#7875;n
hóa có ho&#7841;t tính trong d&#7883;ch não t&#7911;y &#273;ã &#273;&#432;&#7907;c
&#273;&#7883;nh l&#432;&#7907;ng, nh&#432;ng k&#7871;t qu&#7843; &#273;ang c&#7847;n
&#273;&#432;&#7907;c &#273;ánh giá v&#7873; m&#7863;t lâm sàng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Idarubicin &#273;&#432;&#7907;c ch&#7881; &#273;&#7883;nh
dùng ph&#7889;i h&#7907;p v&#7899;i các thu&#7889;c khác &#273;&#7875; &#273;i&#7873;u
tr&#7883; b&#7879;nh b&#7841;ch c&#7847;u th&#7875; t&#7911;y c&#7845;p &#7903;
ng&#432;&#7901;i l&#7899;n và dùng trong &#273;i&#7873;u tr&#7883; b&#7879;nh b&#7841;ch
c&#7847;u th&#7875; lympho c&#7845;p &#7903; tr&#7867; em. Ð&#432;&#7907;c dùng
trong ung th&#432; vú giai &#273;o&#7841;n mu&#7897;n sau th&#7845;t b&#7841;i
v&#7899;i hóa tr&#7883; li&#7879;u tuy&#7871;n &#273;&#7847;u (không bao g&#7891;m
anthracyclin).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Quá m&#7851;n v&#7899;i idarubicin, daunorubicin ho&#7863;c
b&#7845;t c&#7913; thành ph&#7847;n nào c&#7911;a thu&#7889;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ng&#432;&#7901;i cao tu&#7893;i nh&#7841;y c&#7843;m
h&#417;n và d&#7877; b&#7883; các tai bi&#7871;n không mong mu&#7889;n h&#417;n
so v&#7899;i ng&#432;&#7901;i tr&#7867;. Ð&#7889;i v&#7899;i ng&#432;&#7901;i
&#273;ã b&#7883; b&#7879;nh tim, ho&#7863;c b&#7883; suy gi&#7843;m t&#7911;y
x&#432;&#417;ng, ng&#432;&#7901;i &#273;ã &#273;i&#7873;u tr&#7883; b&#7857;ng
các anthracyclin khác, ho&#7863;c b&#7857;ng các thu&#7889;c khác &#273;&#7897;c
cho tim, idarubicin d&#7877; gây &#273;&#7897;c cho tim. X&#7841; li&#7879;u
pháp tr&#432;&#7899;c &#273;ây &#7903; vùng trung th&#7845;t, suy gi&#7843;m n&#7863;ng
ch&#7913;c n&#259;ng gan và/ho&#7863;c th&#7853;n và nhi&#7877;m khu&#7849;n là
nh&#7919;ng y&#7871;u t&#7889; gây nguy c&#417; n&#7863;ng. Trong m&#7897;t s&#7889;
th&#7921;c nghi&#7879;m lâm sàng có ki&#7875;m soát, ng&#432;&#7901;i ta
&#273;ã nh&#7853;n th&#7845;y t&#7927; l&#7879; t&#7917; vong do suy t&#7911;y &#7903;
ng&#432;&#7901;i b&#7879;nh trên 55 tu&#7893;i cao h&#417;n so v&#7899;i nguy
c&#417; khi &#273;i&#7873;u tr&#7883; b&#7857;ng daunorubicin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tr&#432;&#7899;c và trong th&#7901;i gian &#273;i&#7873;u
tr&#7883;, ng&#432;&#7901;i ta &#273;ã khuy&#7871;n cáo ph&#7843;i ki&#7875;m
tra l&#7863;p l&#7841;i nhi&#7873;u l&#7847;n ch&#7913;c n&#259;ng gan và th&#7853;n,
&#273;&#7891;ng th&#7901;i ph&#7843;i ki&#7875;m tra &#273;&#7873;u &#273;&#7863;n
máu và ch&#7913;c n&#259;ng tim.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Phân s&#7889; t&#7889;ng máu t&#7915; th&#7845;t trái
(LVEF) &#273;&#432;&#7907;c coi là cách &#273;o t&#7889;t &#273;&#7875; phát hi&#7879;n
s&#7921; phát tri&#7875;n &#273;áng s&#7907; c&#7911;a b&#7879;nh c&#417; tim.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ph&#7843;i tránh n&#7891;ng &#273;&#7897; acid uric cao
do phá h&#7911;y t&#7871; bào b&#7841;ch c&#7847;u b&#7883; b&#7879;nh và do
&#273;ó c&#7847;n ph&#7843;i giám sát n&#7891;ng &#273;&#7897; acid uric trong
máu và ph&#7843;i &#273;i&#7873;u tr&#7883;. Có th&#7875; &#273;i&#7873;u tr&#7883;
b&#7857;ng allopurinol &#273;&#7875; tránh b&#7879;nh th&#7853;n do acid uric.
Ð&#432;a thêm nhi&#7873;u n&#432;&#7899;c vào c&#417; th&#7875; c&#361;ng quan
tr&#7885;ng &#273;&#7875; th&#7853;n t&#259;ng c&#432;&#7901;ng bài xu&#7845;t xanthin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Idarubicin thoát m&#7841;ch có th&#7875; gây ho&#7841;i t&#7917;
mô t&#7841;i ch&#7895; n&#7863;ng. Thoát m&#7841;ch có th&#7875; x&#7843;y ra,
có ho&#7863;c không kèm theo c&#7843;m giác bu&#7889;t ho&#7863;c rát b&#7887;ng,
ngay c&#7843; khi hút máu tr&#7903; l&#7841;i t&#7889;t vào kim truy&#7873;n. N&#7871;u
có tri&#7879;u ch&#7913;ng ho&#7863;c d&#7845;u hi&#7879;u c&#7911;a thoát m&#7841;ch,
ph&#7843;i ng&#7915;ng ngay tiêm ho&#7863;c truy&#7873;n và b&#7855;t &#273;&#7847;u
l&#7841;i &#7903; m&#7897;t t&#297;nh m&#7841;ch khác.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>N&#7871;u ph&#7843;i dùng idarubicin khi mang thai ho&#7863;c
ng&#432;&#7901;i b&#7879;nh mang thai trong khi &#273;ang &#273;i&#7873;u tr&#7883;
b&#7857;ng idarubicin, ph&#7843;i thông báo cho b&#7879;nh nhân bi&#7871;t nguy
c&#417; có th&#7875; x&#7843;y ra &#273;&#7889;i v&#7899;i thai nhi. Ph&#7909;
n&#7919; có kh&#7843; n&#259;ng sinh &#273;&#7867; ph&#7843;i &#273;&#432;&#7907;c
khuy&#7871;n cáo tránh có thai khi dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#432;a bi&#7871;t thu&#7889;c có bài ti&#7871;t vào s&#7919;a
hay không nh&#432;ng do ti&#7873;m n&#259;ng x&#7843;y ra các tác d&#7909;ng ph&#7909;
nghiêm tr&#7885;ng &#273;&#7889;i v&#7899;i tr&#7867;, nên m&#7865; ph&#7843;i
ng&#7915;ng cho con bú tr&#432;&#7899;c khi dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ði&#7873;u
tr&#7883; b&#7857;ng idarubicin r&#7845;t hay gây các tác d&#7909;ng không mong
mu&#7889;n. Có m&#7897;t s&#7889; tác d&#7909;ng ADR r&#7845;t n&#7863;ng
&#273;&#7871;n n&#7895;i c&#7847;n ph&#7843;i theo dõi ng&#432;&#7901;i b&#7879;nh
ch&#7863;t ch&#7869; trong và sau khi &#273;i&#7873;u tr&#7883;. H&#7847;u h&#7871;t
các tác d&#7909;ng ADR ph&#7909; thu&#7897;c vào li&#7873;u dùng, nh&#432; suy
gi&#7843;m t&#7911;y x&#432;&#417;ng. Tác d&#7909;ng này x&#7843;y ra c&#7845;p
tính và là m&#7897;t ph&#7843;n &#7913;ng không mong mu&#7889;n ph&#7909; thu&#7897;c
li&#7873;u dùng nhi&#7873;u nh&#7845;t, &#273;i cùng v&#7899;i nguy c&#417;
&#273;&#7897;c cho tim. Tr&#7915; tác d&#7909;ng ph&#7909; gây b&#7879;nh
c&#417; tim, các tác d&#7909;ng không mong mu&#7889;n khác &#273;&#7873;u có th&#7875;
h&#7891;i ph&#7909;c &#273;&#432;&#7907;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nguy
c&#417; nhi&#7877;m khu&#7849;n có th&#7875; r&#7845;t n&#7863;ng và &#273;ôi
khi d&#7851;n &#273;&#7871;n t&#7917; vong khi &#273;i&#7873;u tr&#7883;
idarubicin &#273;&#417;n &#273;&#7897;c ho&#7863;c khi ph&#7889;i h&#7907;p v&#7899;i
cytosin arabinosid. Ð&#7897;c tính &#273;&#7889;i v&#7899;i tim nh&#432; suy
tim n&#7863;ng, lo&#7841;n nh&#7883;p c&#7845;p n&#7863;ng ho&#7863;c b&#7879;nh
c&#417; tim có th&#7875; &#273;e d&#7885;a tính m&#7841;ng ng&#432;&#7901;i b&#7879;nh.
Ð&#7897;c v&#7899;i tim có th&#7875; xu&#7845;t hi&#7879;n trong quá trình
&#273;i&#7873;u tr&#7883; ho&#7863;c m&#7897;t vài tu&#7847;n sau khi &#273;ã
ng&#7915;ng &#273;i&#7873;u tr&#7883;. Nguy c&#417; gây &#273;&#7897;c c&#417;
tim có th&#7875; cao h&#417;n, &#7903; ng&#432;&#7901;i b&#7879;nh &#273;&#432;&#7907;c
chi&#7871;u tia &#273;&#7891;ng th&#7901;i ho&#7863;c t&#7915; tr&#432;&#7899;c
vào vùng trung th&#7845;t - tr&#432;&#7899;c tim ho&#7863;c &#7903; ng&#432;&#7901;i
b&#7879;nh thi&#7871;u máu, suy t&#7911;y, nhi&#7877;m khu&#7849;n, viêm màng
ngoài tim do b&#7879;nh b&#7841;ch c&#7847;u và/ho&#7863;c viêm c&#417; tim.
Nguy c&#417; cao h&#417;n khi li&#7873;u tích l&#361;y v&#432;&#7907;t 100 mg/m<sup>2</sup>.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Viêm
niêm m&#7841;c mi&#7879;ng th&#432;&#7901;ng xu&#7845;t hi&#7879;n trong vòng 3
- 10 ngày sau khi b&#7855;t &#273;&#7847;u &#273;i&#7873;u tr&#7883;. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#432;&#7901;ng
g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7847;n
kinh trung &#432;&#417;ng: Ðau &#273;&#7847;u, s&#7889;t, co gi&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ngoài
da: R&#7909;ng tóc, ban &#273;&#7887;, mày &#273;ay.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tiêu
hóa: Viêm niêm m&#7841;c, bu&#7891;n nôn, nôn, &#7881;a ch&#7843;y, viêm mi&#7879;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ti&#7871;t
ni&#7879;u - sinh d&#7909;c: N&#432;&#7899;c ti&#7875;u &#273;&#7887;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Máu: Ch&#7843;y
máu, thi&#7871;u máu, &#7913;c ch&#7871; t&#7911;y x&#432;&#417;ng, gi&#7843;m
b&#7841;ch c&#7847;u (th&#7845;p nh&#7845;t: 8 - 29 ngày).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#7841;i
ch&#7895;: Ho&#7841;i t&#7917; ch&#7895; thoát m&#7841;ch, d&#7843;i ban &#273;&#7887;,
r&#7897;p da.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7847;n
kinh - c&#417; - x&#432;&#417;ng: B&#7879;nh th&#7847;n kinh ngo&#7841;i vi.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Khác:
Nhi&#7877;m khu&#7849;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tim m&#7841;ch:
Lo&#7841;n nh&#7883;p tim, bi&#7871;n &#273;&#7893;i &#273;i&#7879;n tim, b&#7879;nh
c&#417; tim, suy tim sung huy&#7871;t, nhi&#7877;m &#273;&#7897;c c&#417; tim,
lo&#7841;n nh&#7883;p tim c&#7845;p tính &#273;e d&#7885;a tính m&#7841;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7897;i
ti&#7871;t và chuy&#7875;n hóa: T&#259;ng acid uric huy&#7871;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Gan: T&#259;ng enzym gan ho&#7863;c bilirubin.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Li&#7873;u l&#432;&#7907;ng và cách
dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Cách dùng:</span></i><span lang=DE style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;mso-ansi-language:DE'> Pha
idarubicin l&#7885; 5 mg, 10 mg và 20 mg t&#432;&#417;ng &#7913;ng v&#7899;i 5
ml, 10 ml và 20 ml dung d&#7883;ch tiêm natri clorid 0,9% &#273;&#7875; có n&#7891;ng
&#273;&#7897; cu&#7889;i cùng 1mg/ml idarubicin. Không dùng dung môi có ch&#7845;t
kìm khu&#7849;n. Ph&#7843;i tiêm ch&#7853;m (10 - 15 phút) vào &#7889;ng dây
truy&#7873;n cho ch&#7843;y t&#7921; do vào t&#297;nh m&#7841;ch dung d&#7883;ch
natri clorid 0,9% ho&#7863;c glucose 5%. Dây truy&#7873;n ph&#7843;i n&#7889;i
vào m&#7897;t kim b&#432;&#7899;m và nên lu&#7891;n vào m&#7897;t t&#297;nh m&#7841;ch
l&#7899;n. Lo&#7841;i b&#7887; dung d&#7883;ch thu&#7889;c không dùng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Chú ý: Ph&#7843;i &#273;eo kính b&#7843;o v&#7879;, mang
g&#259;ng tay, m&#7863;c áo choàng khi pha và tiêm truy&#7873;n thu&#7889;c
&#273;&#7875; tránh thu&#7889;c dính vào da và nh&#7845;t là vào m&#7855;t. N&#7871;u
da b&#7883; dính thu&#7889;c ph&#7843;i r&#7917;a ngay b&#7857;ng xà phòng và
n&#432;&#7899;c th&#7853;t k&#7929;. N&#7871;u m&#7855;t b&#7883; dính thu&#7889;c
ph&#7843;i t&#432;&#7899;i r&#7917;a ngay theo ph&#432;&#417;ng pháp chu&#7849;n
c&#7911;a nhãn khoa.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Li&#7873;u dùng:</span></i><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'> Tiêm t&#297;nh m&#7841;ch:<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tr&#7867; em</span></i><span lang=DE style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;mso-ansi-language:DE'>: B&#7879;nh
b&#7841;ch c&#7847;u: 10 - 12 mg/m<sup>2</sup> di&#7879;n tích c&#417; th&#7875;,
1 l&#7847;n m&#7895;i ngày, dùng trong 3 ngày, c&#7913; 3 tu&#7847;n nh&#7855;c
l&#7841;i. Các b&#7879;nh u &#273;&#7863;c: 5 mg/m<sup>2</sup> di&#7879;n tích
c&#417; th&#7875;, 1 l&#7847;n m&#7895;i ngày, dùng trong 3 ngày, c&#7913; 3 tu&#7847;n
dùng nh&#7855;c l&#7841;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ng&#432;&#7901;i l&#7899;n</span></i><span lang=DE
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>: 12 mg/m<sup>2</sup>/ngày, trong 3 ngày, tiêm t&#297;nh
m&#7841;ch ch&#7853;m (10 - 15 phút) ph&#7889;i h&#7907;p v&#7899;i cytosin
arabinosid.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Cytosin arabinosid &#273;&#432;&#7907;c dùng v&#7899;i li&#7873;u
100 mg/m<sup>2</sup>/ngày trong 7 ngày, truy&#7873;n liên t&#7909;c ho&#7863;c
v&#7899;i li&#7873;u &#273;&#7847;u tiên 25 mg/m<sup>2</sup> tiêm c&#7843; li&#7873;u
r&#7891;i ti&#7871;p theo truy&#7873;n liên t&#7909;c 200 mg/m<sup>2</sup>/ngày,
trong 5 ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>V&#7899;i ng&#432;&#7901;i suy th&#7853;n, &#273;i&#7873;u
ch&#7881;nh li&#7873;u nh&#432; sau: N&#7891;ng &#273;&#7897; creatinin huy&#7871;t
thanh l&#7899;n h&#417;n ho&#7863;c b&#7857;ng 2 mg/decilít, li&#7873;u gi&#7843;m
25%.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>V&#7899;i ng&#432;&#7901;i suy gan, n&#7871;u bilirubin
1,5 - 5 mg/decilít ho&#7863;c aspartat transaminase 60 - 180 &#273;&#417;n v&#7883;
thì gi&#7843;m li&#7873;u 50%. N&#7871;u bilirubin &gt; 5 mg/decilít ho&#7863;c
aspartat transaminase l&#7899;n h&#417;n 180 &#273;&#417;n v&#7883; thì không
&#273;&#432;&#7907;c dùng thu&#7889;c.<b> <o:p></o:p></b></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>H&#432;&#7899;ng d&#7851;n cách x&#7917; trí khi thu&#7889;c
thoát m&#7841;ch:<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#432;&#7901;m ngay &#273;á trong 30 - 60 phút, sau
&#273;ó, b&#7887; ra r&#7891;i l&#7841;i ch&#432;&#7901;m sau m&#7895;i 15
phút. Ch&#432;&#7901;m trong m&#7897;t ngày. Có th&#7875; dùng b&#7885;c
&#273;á ho&#7863;c túi ch&#432;&#7901;m n&#432;&#7899;c &#273;á. Làm l&#7841;nh
ch&#7895; &#273;au trong 24 gi&#7901; n&#7871;u b&#7879;nh nhân ch&#7883;u
&#273;&#432;&#7907;c. Nâng cao chi có thu&#7889;c thoát m&#7841;ch và &#273;&#7875;
ngh&#7881; trong vòng 24 - 28 gi&#7901;, sau &#273;ó &#273;&#7875; tr&#7903; l&#7841;i
ho&#7841;t &#273;&#7897;ng bình th&#432;&#7901;ng n&#7871;u ch&#7883;u
&#273;&#432;&#7907;c. Ch&#432;&#7901;m &#273;á s&#7869; &#7913;c ch&#7871;
&#273;&#432;&#7907;c &#273;&#7897;c tính t&#7871; bào c&#7911;a thu&#7889;c gây
ph&#7891;ng r&#7897;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Không &#273;&#432;&#7907;c ch&#432;&#7901;m nóng ho&#7863;c
dùng natri bicarbonat vì có th&#7875; gây t&#7893;n h&#7841;i mô t&#7841;i ch&#7895;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>T&#432;&#417;ng tác thu&#7889;c<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>T&#432;&#417;ng tác gây t&#259;ng suy t&#7911;y khi ph&#7889;i
h&#7907;p v&#7899;i các thu&#7889;c khác &#273;&#7875; &#273;i&#7873;u tr&#7883;
b&#7879;nh b&#7841;ch c&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>T&#432;&#417;ng tác gây t&#259;ng &#273;&#7897;c tim &#7903;
nh&#7919;ng ng&#432;&#7901;i b&#7879;nh tr&#432;&#7899;c &#273;ã &#273;i&#7873;u
tr&#7883; b&#7857;ng các thu&#7889;c kìm t&#7871; bào gây &#273;&#7897;c tim.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>M&#7897;t s&#7889; thu&#7889;c khác có th&#7875;
t&#432;&#417;ng tác v&#7899;i các anthracyclin nh&#432;: Các vinca alcaloid
(kháng chéo), amphotericin B (t&#259;ng h&#7845;p thu thu&#7889;c) và
cyclosporin và streptomicin (gi&#7843;m &#273;&#7897; thanh th&#7843;i thu&#7889;c
và t&#259;ng &#273;&#7897;c tính). Ða s&#7889; t&#432;&#417;ng tác thu&#7889;c
&#273;ó m&#7899;i ch&#7881; &#273;&#432;&#7907;c nghiên c&#7913;u in vitro, và
c&#7847;n ph&#7843;i &#273;&#432;&#7907;c lâm sàng xác nh&#7853;n.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Ð&#7897; &#7893;n &#273;&#7883;nh và
b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>B&#7843;o qu&#7843;n b&#7897;t &#273;ông khô &#7903; nhi&#7879;t
&#273;&#7897; phòng và tránh ánh sáng. Dung d&#7883;ch &#273;ã pha 1mg/ml gi&#7919;
&#273;&#432;&#7907;c &#7893;n &#273;&#7883;nh &#7903; nhi&#7879;t &#273;&#7897;
phòng (15 - 30<sup>o</sup>C) trong 72 gi&#7901;, và &#7903; l&#7841;nh (2 - 8<sup>o</sup>C)
trong 7 ngày.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Idarubicin
t&#432;&#417;ng k&#7925; v&#7899;i fluorouracil, etoposid, dexamethason,
heparin, hydrocortison, methotrexat, vincristin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tr&#7915; khi có nh&#7919;ng ch&#7881; &#273;&#7883;nh
&#273;&#7863;c bi&#7879;t, nói chung không nên hòa tr&#7897;n v&#7899;i b&#7845;t
kì thu&#7889;c nào.<b> <o:p></o:p></b></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Tri&#7879;u ch&#7913;ng quá li&#7873;u là: Suy t&#7911;y
n&#7863;ng và t&#259;ng nhi&#7877;m &#273;&#7897;c &#273;&#432;&#7901;ng tiêu
hóa. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Ch&#432;a có thu&#7889;c gi&#7843;i &#273;&#7897;c &#273;&#7863;c
hi&#7879;u. Ði&#7873;u tr&#7883; h&#7895; tr&#7907; là c&#7847;n thi&#7871;t,
bao g&#7891;m: Truy&#7873;n ti&#7875;u c&#7847;u, kháng sinh, &#273;i&#7873;u
tr&#7883; tri&#7879;u ch&#7913;ng viêm niêm m&#7841;c. Th&#7849;m tách màng b&#7909;ng
và th&#7849;m tách th&#7853;n nhân t&#7841;o c&#361;ng không ch&#7855;c ch&#7855;n
là có hi&#7879;u qu&#7843; &#273;i&#7873;u tr&#7883; và gi&#7843;m &#273;&#7897;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-ansi-language:DE'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;
mso-ansi-language:DE'>Thu&#7889;c ph&#7843;i &#273;&#432;&#7907;c kê
&#273;&#417;n và bán theo &#273;&#417;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Idarubicin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:59 GMT -->
</html>
